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  EVIDENCE-BASED ANSWER 
Selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants (TCAs), benzodiazepines (BDZs), and 
cognitive behavioral therapy (CBT) are effective for panic disorder (PD) with or without agoraphobia (NNT5 for 
complete remission). SSRIs may be most effective, but BDZs work faster. Clomipramine is more effective than 
other TCAs. CBT improves response and decreases relapse rates when used with medication. Severe 
symptoms may warrant short-term use of a BDZ until other therapies take effect (Grade of recommendation: A, 
based on systematic reviews of randomized clinical trials (RCTs); high quality RCTs). 
  EVIDENCE SUMMARY 
SSRIs were more effective than imipramine or alprazolam in a meta-analysis,1 but equivalent to these drugs in 
an effect-size analysis.2 The absolute difference in efficacy is difficult to determine; few studies directly compare 
SSRIs with other drugs. In 2 randomized head-to-head trials,3,4 remission rates (eliminating symptoms) were 
50%-65% for paroxetine, 37%-53% for clomipramine, and 32%-34% for placebo after 9-12 weeks of therapy; 
differences between the 2 active drugs were not significant. Clomipramine is serotoninergic and was more 
effective than other tricyclics in an RCT.5 Adding a BDZ to an SSRI for the first 3 weeks can rapidly stabilize 
symptoms6 (Table). 
Two meta-analyses concluded that CBT is as effective as antidepressants or BDZs during acute treatment7 and 
during long-term follow-up (31-121 weeks).8 CBT and imipramine each reduce symptoms in 45%-48% of 
patients; combining them reduces symptoms in 60%.9 Imipramine is more effective initially; CBT is more 
durable9 but effects may be therapist-dependent. When used in conjunction with medication, graded exposure 
to panicinducing situations reduces agoraphobia7 but does not improve relapse rates.8 Behavioral therapy with 
exposure homework has good long-term results.10 
An adequate trial of medication requires 6-8 weeks.11 Before treating, evaluate patients for comorbid mood, 
anxiety, personality, substance use, or medical disorders, which affect 40%-50% of patients with panic disorder, 
and may influence the choice of treatment.12 Current practice is to slowly taper and discontinue medication after 
12-18 months of maintenance treatment12 if there are no significant residual symptoms, no increased 
psychosocial stressors, and no history of severe or recurrent relapse. 
 
TABLE 
Drugs used to treat panic disorder 
Drug Class Side Effects Other Considerations 
Selective 
serotonin 
reuptake 
inhibitors 
Nausea (10-30%), 
drowsiness (7-20%), 
insomnia (< 10%), 
nervousness(< 10%), 
sexual dysfunction (< 
10% but underreported). 
All equivalently effective. 
Some patients may 
respond to lower than usual 
doses. Start at half the 
usual dose. 
Tricyclic 
antidepressants 
Dry mouth (> 45%), 
dizziness (2%), 
constipation (15%), 
sweating (15%), tremors 
(15%), fatigue (< 10%) 
Requires more time to 
titrate to treatment dose. 
Clomipramine more 
effective. Some patients 
with panic disorder are 
extremely sensitive both to 
the therapeutic and 
adverse effects of TCAs. 
Start at very low doses. 
Benzodiazepines Somnolence (15-34%) 
and impaired coordination 
(6-22%). Potential for 
physical dependence and 
withdrawal symptoms, but 
psychological addiction 
has not been a significant 
problem in clinical trials. 
Faster onset of action than 
antidepressants, but do not 
treat comorbid depression 
and are more difficult to 
discontinue. 
  RECOMMENDATIONS FROM OTHERS 
The American Psychiatric Association Guideline states that CBT and pharmacotherapy are equivalently 
effective, and that SSRIs, TCAs, BDZs, and MAOIs are equivalently effective.12 The International Consensus 
Group on Depression and Anxiety concludes that SSRIs, TCAs, and BDZs are effective. SSRIs and BDZs are 
tolerated better than TCAs, and BDZs act faster (1 week vs. 4-8 weeks).11 
Read a Clinical Commentary by William A. Hensel, MD, at www.fpin.org. 
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